메뉴 건너뛰기




Volumn , Issue , 2006, Pages 509-518

The verifynow system

Author keywords

[No Author keywords available]

Indexed keywords


EID: 51549094106     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369367-9/50789-8     Document Type: Chapter
Times cited : (2)

References (27)
  • 1
    • 0027737994 scopus 로고
    • Lack of usefulness of prolonged bleeding time in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody
    • M.M. Bernardi, et al. (1993) Lack of usefulness of prolonged bleeding time in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. Am J Cardiol 72 1121-1125.
    • (1993) Am J Cardiol , vol.72 , pp. 1121-1125
    • Bernardi, M.M.1
  • 2
    • 0025166288 scopus 로고
    • A critical reappraisal of the bleeding time
    • R. Rogers and J. Levin (1990) A critical reappraisal of the bleeding time. Sem Thromb Hemost 16 1-20.
    • (1990) Sem Thromb Hemost , vol.16 , pp. 1-20
    • Rogers, R.1    Levin, J.2
  • 3
    • 0018857958 scopus 로고
    • Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: Defective platelet-fibrinogen interaction in thrombasthenia
    • B.S. Coller (1980) Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: Defective platelet-fibrinogen interaction in thrombasthenia. Blood 55 169-178.
    • (1980) Blood , vol.55 , pp. 169-178
    • Coller, B.S.1
  • 4
    • 0025821449 scopus 로고
    • Monoclonal antibodies to platelet GPIIb/IIIa as antithrombotic agents
    • B.S. Coller, et al. (1991) Monoclonal antibodies to platelet GPIIb/IIIa as antithrombotic agents. Ann NY Acad Sci 614 193-213.
    • (1991) Ann NY Acad Sci , vol.614 , pp. 193-213
    • Coller, B.S.1
  • 5
    • 0031058513 scopus 로고    scopus 로고
    • Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade
    • B.S. Coller, D. Lang and L.E. Scudder (1997) Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade. Circulation 95 860-867.
    • (1997) Circulation , vol.95 , pp. 860-867
    • Coller, B.S.1    Lang, D.2    Scudder, L.E.3
  • 6
    • 0033537494 scopus 로고    scopus 로고
    • Rapid platelet-function assay: An automated and quantitative cartridge-based method
    • J.W. Smith, et al. (1999) Rapid platelet-function assay: An automated and quantitative cartridge-based method. Circulation 99 620-625.
    • (1999) Circulation , vol.99 , pp. 620-625
    • Smith, J.W.1
  • 7
    • 0347359012 scopus 로고    scopus 로고
    • 2+responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced prostaglandin E1
    • S.C. Fox, M.W. Behan and S. Heptinstall (2004) Inhibition of ADP-induced intracellular Ca 2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced prostaglandin E1. Cell Calcium 35 39-46.
    • (2004) Cell Calcium , vol.35 , pp. 39-46
    • Fox, S.C.1    Behan, M.W.2    Heptinstall, S.3
  • 8
    • 0036242793 scopus 로고    scopus 로고
    • The Ultegra rapid plateletfunction assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abcix
    • G.L. Wheeler, et al. (2002) The Ultegra rapid plateletfunction assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abcix. Am Heart J 143 602-611.
    • (2002) Am Heart J , vol.143 , pp. 602-611
    • Wheeler, G.L.1
  • 9
    • 0035070161 scopus 로고    scopus 로고
    • A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary interventio receiving abciximab, eptifibatide, or tirofi — ban
    • D.I. Simon, et al. (2001) A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary interventio receiving abciximab, eptifibatide, or tirofi — ban. Cathet Cardiovasc Intervent 52 425-432.
    • (2001) Cathet Cardiovasc Intervent , vol.52 , pp. 425-432
    • Simon, D.I.1
  • 10
    • 0000742817 scopus 로고    scopus 로고
    • The Accumetrics Rapid Platelet Function Analyzer (RPFA) to monitor platelet aggregation during oral administration of a GPIIb/IIIa antagonist (abstract)
    • P. Theroux, et al. (1999) The Accumetrics Rapid Platelet Function Analyzer (RPFA) to monitor platelet aggregation during oral administration of a GPIIb/IIIa antagonist (abstract). J Am Coll Cardiol 33(Suppl A), 330A.
    • (1999) J Am Coll Cardiol , vol.33 , pp. 330A
    • Theroux, P.1
  • 11
    • 2942555599 scopus 로고    scopus 로고
    • Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer
    • A. Malinin, et al. (2004) Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer. Blood Coagul Fibrinolysis 15 295-301.
    • (2004) Blood Coagul Fibrinolysis , vol.15 , pp. 295-301
    • Malinin, A.1
  • 12
    • 18244392669 scopus 로고    scopus 로고
    • Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregomet
    • P. Harrison, et al. (2005) Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregomet. Stroke 36 1001-1005.
    • (2005) Stroke , vol.36 , pp. 1001-1005
    • Harrison, P.1
  • 13
    • 27744516843 scopus 로고    scopus 로고
    • Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel. Results of the ISAR-CHOICE (Intracoronary Stentin Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial
    • N. von Beckerath, et al. (2005) Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel. Results of the ISAR-CHOICE (Intracoronary Stentin Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation 112 2946-2950.
    • (2005) Circulation , vol.112 , pp. 2946-2950
    • von Beckerath, N.1
  • 14
    • 84884747481 scopus 로고    scopus 로고
    • Correlation between platelet response units measured with a point-of-care test and ADPinduced platelet aggregation assessed with conventional optical aggregom
    • (Abstract Supplement)
    • N. von Beckerath, et al. (2005) Correlation between platelet response units measured with a point-of-care test and ADPinduced platelet aggregation assessed with conventional optical aggregom. Eur Heart J 26 479. (Abstract Supplement)
    • (2005) Eur Heart J , vol.26 , pp. 479
    • von Beckerath, N.1
  • 15
    • 15944383861 scopus 로고    scopus 로고
    • Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases
    • B. Aleil, et al. (2005) Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 3 85-92.
    • (2005) J Thromb Haemost , vol.3 , pp. 85-92
    • Aleil, B.1
  • 16
    • 0024848055 scopus 로고
    • Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, p aggregation, and blockade of GPIIb/IIIa receptors
    • B.S. Coller, et al. (1989) Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, p aggregation, and blockade of GPIIb/IIIa receptors. Circulation 80 1766-1774.
    • (1989) Circulation , vol.80 , pp. 1766-1774
    • Coller, B.S.1
  • 17
    • 0023838863 scopus 로고
    • Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet antibody in a dog model
    • H.K. Gold, et al. (1988) Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet antibody in a dog model. Circulation 77 670-677.
    • (1988) Circulation , vol.77 , pp. 670-677
    • Gold, H.K.1
  • 18
    • 0035853027 scopus 로고    scopus 로고
    • Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event following percutaneous coronary intervention. Results of (AU-Assessing Ultegra) multicenter study
    • S. Steinhubl, et al. (2001) Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event following percutaneous coronary intervention. Results of (AU-Assessing Ultegra) multicenter study. Circulation 103 1403-1409.
    • (2001) Circulation , vol.103 , pp. 1403-1409
    • Steinhubl, S.1
  • 19
    • 0036711197 scopus 로고    scopus 로고
    • Effectiveness of tirofi ban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)
    • A.S. Kini, et al. (2002) Effectiveness of tirofi ban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study). Am J Cardiol 90 526-529.
    • (2002) Am J Cardiol , vol.90 , pp. 526-529
    • Kini, A.S.1
  • 20
    • 10744230699 scopus 로고    scopus 로고
    • Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA
    • J.C. Wang, et al. (2003) Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA. Am J Cardiol 92 1492-1494.
    • (2003) Am J Cardiol , vol.92 , pp. 1492-1494
    • Wang, J.C.1
  • 21
    • 1542708471 scopus 로고    scopus 로고
    • Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
    • W.H. Chen, et al. (2004) Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43 1122-1126.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 1122-1126
    • Chen, W.H.1
  • 22
    • 24944525789 scopus 로고    scopus 로고
    • Relation of aspirin resistance to coronary flow reserve in patients undergoing elective percutaneous coronary intervention
    • W.H. Chen, et al. (2005) Relation of aspirin resistance to coronary flow reserve in patients undergoing elective percutaneous coronary intervention. Am J Cardiol 96 760-763.
    • (2005) Am J Cardiol , vol.96 , pp. 760-763
    • Chen, W.H.1
  • 23
    • 21244446907 scopus 로고    scopus 로고
    • Low-dose aspirin increases aspirin resistance in patients with coronary artery disease
    • P. Lee, et al. (2005) Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med 118 723-727.
    • (2005) Am J Med , vol.118 , pp. 723-727
    • Lee, P.1
  • 25
    • 24944474901 scopus 로고    scopus 로고
    • Aspirin resistance: Position paper of the Working Group on Aspirin Resistance
    • A.D. Michelson, et al. (2005) Aspirin resistance: Position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 3 1309-1311.
    • (2005) J Thromb Haemost , vol.3 , pp. 1309-1311
    • Michelson, A.D.1
  • 26
    • 8344221349 scopus 로고    scopus 로고
    • Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
    • S. Matetzky, et al. (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109 3171-3175.
    • (2004) Circulation , vol.109 , pp. 3171-3175
    • Matetzky, S.1
  • 27
    • 0038291914 scopus 로고    scopus 로고
    • Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement
    • I. Muller, et al. (2003) Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 89 783-787.
    • (2003) Thromb Haemost , vol.89 , pp. 783-787
    • Muller, I.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.